These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

788 related items for PubMed ID: 19198009

  • 1. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.
    Bonello L, De Labriolle A, Lemesle G, Steinberg DH, Roy P, Torguson R, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R.
    Catheter Cardiovasc Interv; 2009 Jun 01; 73(7):866-70. PubMed ID: 19198009
    [Abstract] [Full Text] [Related]

  • 2. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB, Wiviott SD, Buros JL, Zorkun C, Tariq MU, Antman EM, Braunwald E, Gibson CM, TIMI Study Group.
    Am Heart J; 2009 Sep 01; 158(3):e21-6. PubMed ID: 19699846
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes.
    Feldman DN, Fakorede F, Minutello RM, Bergman G, Moussa I, Wong SC.
    Am J Cardiol; 2010 Feb 01; 105(3):323-32. PubMed ID: 20102943
    [Abstract] [Full Text] [Related]

  • 4. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.
    Han YL, Wang B, Li Y, Xu K, Wang SL, Jing QM, Wang ZL, Wang DM, Ma YY, Wang G.
    Chin Med J (Engl); 2009 Apr 05; 122(7):793-7. PubMed ID: 19493391
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality.
    Banerjee S, Varghese C, Samuel J, Weideman RA, Little BB, Kelly KC, Rao SV, Reilly RF, Brilakis ES.
    Am J Cardiol; 2008 Nov 01; 102(9):1159-62. PubMed ID: 18940284
    [Abstract] [Full Text] [Related]

  • 6. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K.
    Thromb Haemost; 2010 Dec 01; 104(6):1211-8. PubMed ID: 20941464
    [Abstract] [Full Text] [Related]

  • 7. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX.
    Thromb Res; 2009 May 01; 124(1):46-51. PubMed ID: 19041120
    [Abstract] [Full Text] [Related]

  • 8. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
    James S, Akerblom A, Cannon CP, Emanuelsson H, Husted S, Katus H, Skene A, Steg PG, Storey RF, Harrington R, Becker R, Wallentin L.
    Am Heart J; 2009 Apr 01; 157(4):599-605. PubMed ID: 19332184
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
    Ma HY, Zhou YJ, Dick RJ, Shi DM, Liu YY, Cheng WJ, Guo YH, Wang JL, Ge HL.
    Chin Med J (Engl); 2008 May 20; 121(10):887-91. PubMed ID: 18706201
    [Abstract] [Full Text] [Related]

  • 10. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
    Dosh K, Berger PB, Marso S, van Lente F, Brennan DM, Charnigo R, Topol EJ, Steinhubl S.
    Circ Cardiovasc Interv; 2009 Dec 20; 2(6):503-12. PubMed ID: 20031767
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S, Kashinath RC, Kadri S, Orig MN, Khadra S.
    Coron Artery Dis; 2010 Aug 20; 21(5):261-5. PubMed ID: 20555264
    [Abstract] [Full Text] [Related]

  • 12. Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome.
    Ho PM, Fihn SD, Wang L, Bryson CL, Lowy E, Maynard C, Magid DJ, Peterson ED, Jesse RL, Rumsfeld JS.
    Am Heart J; 2007 Nov 20; 154(5):846-51. PubMed ID: 17967588
    [Abstract] [Full Text] [Related]

  • 13. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.
    Cannon CP, Husted S, Harrington RA, Scirica BM, Emanuelsson H, Peters G, Storey RF, DISPERSE-2 Investigators.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1844-51. PubMed ID: 17980250
    [Abstract] [Full Text] [Related]

  • 14. Clopidogrel loading doses and outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Wang C, Kereiakes DJ, Bae JP, McCollam P, He J, Griffin B.
    J Invasive Cardiol; 2007 Oct 06; 19(10):431-6. PubMed ID: 17906345
    [Abstract] [Full Text] [Related]

  • 15. The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.
    Butler MJ, Eccleston D, Clark DJ, Ajani AE, Andrianopoulos N, Brennan A, New G, Black A, Szto G, Reid CM, Yan BP, Shaw JA, Dart AM, Duffy SJ, Melbourne Interventional Group.
    Am Heart J; 2009 May 06; 157(5):899-907. PubMed ID: 19376319
    [Abstract] [Full Text] [Related]

  • 16. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E, TIMI Study Group.
    Am Heart J; 2008 Jan 06; 155(1):133-9. PubMed ID: 18082504
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
    Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E, TRITON-TIMI 38 Investigators.
    Am Heart J; 2006 Oct 06; 152(4):627-35. PubMed ID: 16996826
    [Abstract] [Full Text] [Related]

  • 18. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
    L'Allier PL, Aronow HD, Cura FA, Bhatt DL, Albirini A, Schneider JP, Topol EJ, Ellis SG.
    Can J Cardiol; 2003 Aug 06; 19(9):1041-6. PubMed ID: 12915931
    [Abstract] [Full Text] [Related]

  • 19. High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease.
    Migliorini A, Valenti R, Marcucci R, Parodi G, Giuliani G, Buonamici P, Cerisano G, Carrabba N, Gensini GF, Abbate R, Antoniucci D.
    Circulation; 2009 Dec 01; 120(22):2214-21. PubMed ID: 19917884
    [Abstract] [Full Text] [Related]

  • 20. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes.
    Riezebos RK, Ronner E, Ter Bals E, Slagboom T, Smits PC, ten Berg JM, Kiemeneij F, Amoroso G, Patterson MS, Suttorp MJ, Tijssen JG, Laarman GJ, OPTIMA trial.
    Heart; 2009 May 01; 95(10):807-12. PubMed ID: 19098058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.